Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vallum Corporation is a medical technology company specializing in advanced surface treatments for orthopedic implants. The company's flagship technology, PEEKplus, is a proprietary nanotextured surface processing for Polyetheretherketone (PEEK) spinal interbody fusion devices. This technology is designed to improve the osteoconductive properties of PEEK without the use of coatings, promoting better bone-to-implant integration while maintaining radiolucency. Vallum received the first FDA 510(k) clearance for a nanotextured PEEK surface, positioning it as a leader in spinal implant innovation. The company aims to enhance clinical outcomes in spinal surgery by providing a superior interface for bone growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vallum Corporation.